Drug Type Universal CAR-T |
Synonyms CNK UT009, CNKUT009 |
Action modulators |
Mechanism BCMA modulators(B-cell maturation protein modulators), CD70 modulators(CD70 antigen modulators), NKG2D modulators(NKG2-D type II integral membrane protein modulators) |
Inactive Indication- |
Originator Organization |
Active Organization |
Inactive Organization- |
License Organization- |
Drug Highest PhaseClinical |
First Approval Date- |
RegulationOrphan Drug (United States) |
| Indication | Highest Phase | Country/Location | Organization | Date |
|---|---|---|---|---|
| Diabetes Mellitus, Type 1 | Clinical | China | 06 May 2025 | |
| Graft Rejection | Clinical | China | 01 Jan 2025 | |
| Acute Graft Versus Host Disease | Preclinical | United States | 12 Sep 2025 |





